Medtronic Invades Dialysis Market With Bellco Buy
This article was originally published in Clinica
Executive Summary
Medtronic PLC is expanding its presence in the end-stage renal disease device market with the acquisition of hemodialysis company Bellco Health Corp.
You may also be interested in...
FDA Clears Medtronic’s CRRT System For Pediatric Kidney Disease
The de novo clearance makes the Carpediem system the first commercially available system indicated for continuous renal replacement therapy in pediatric patients.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.